Multiple viral coinfections among HIV/AIDS patients in China

BioScience Trends

Volumn 5, Issue 1, 2011, Pages 1-9

  He, Na ^a   Chen, Li ^a   Lin, Haijiang ^a,b   Zhang, Man ^c   Wei, Jun ^d   Yang, Jianhua ^e   Gabrio, Jenna ^f   Rui, Baoling ^c   Zhang, Zuo Feng ^g   Fu, Zhuohua ^a   Ding, Yingying ^a,g   Zhao, Genming ^a   Jiang, Qingwu ^a   Detels, Roger ^g  

^a FUDAN UNIVERSITY   (China)

^b Taizhou City Center for Disease Control and Prevention   (China)

^c Urumqi City Center for Disease Control and Prevention   (China)

^d Yuncheng Prefecture Center for Disease Control and Prevention   (China)

^e Yingjiang County Center for Disease Control and Prevention   (China)

^f GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Chinese; Coinfection; EBV; HBV HCV; HIV; HSV

Indexed keywords

HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; HUMAN HERPESVIRUS 4; HUMAN IMMUNODEFICIENCY VIRUS; SIMPLEXVIRUS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE; ARTICLE; CHINA; CROSS-SECTIONAL STUDY; EPSTEIN BARR VIRUS INFECTION; FEMALE; GENITAL HERPES; HEPATITIS B; HEPATITIS C; HERPES SIMPLEX; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MALE; SEX DIFFERENCE; SOCIOECONOMICS; STATISTICAL MODEL;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AGE FACTORS; CHINA; CROSS-SECTIONAL STUDIES; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HEPATITIS B; HEPATITIS C; HERPES GENITALIS; HERPES SIMPLEX; HIV SEROPREVALENCE; HUMANS; LOGISTIC MODELS; MALE; SEX FACTORS; SOCIOECONOMIC FACTORS;

EID: 79960632297     PISSN: 18817815     EISSN: 18817823     Source Type: Journal    
DOI: 10.5582/bst.2011.v5.1.1     Document Type: Article

References (36)

1. Sulkowski MS, Moore RD, Mehta SH, Chaisson RE, Thomas DL. Hepatitis C and progression of HIV disease. JAMA. 2002; 288:199-206.
2. Rossi SJ, Volberding PA, Wright TL. Does hepatitis C virus infection increase the risk of HIV disease progression? JAMA. 2002; 288:241-243.
3. Nikolopoulos GK, Paraskevis D, Hatzitheodorou E, Moschidis Z, Sypsa V, Zavitsanos X, Kalapothaki V, Hatzakis A. Impact of hepatitis B virus infection on the progression of AIDS and mortality in HIV-infected individuals: A cohort study and meta-analysis. Clin Infect Dis. 2009; 48:1763-1771.
4. Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, Heeren T, Koziel MJ. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: A meta-analysis. Clin Infect Dis. 2001; 33:562-569.
5. Thein HH, Yi Q, Dore GJ, Krahn MD. Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: A meta-analysis. AIDS. 2008; 22:1979-1991.
6. Calistri A, Parolin C, Palù G. Herpes simplex virus type 1 can either suppress or enhance human immunodeficiency virus type 1 replication in CD4-positive T lymphocytes. J Med Virol. 2003; 70:163-170.
7. Kucera LS, Leake E, Iyer N, Raben D, Myrvik QN. Human immunodeficiency virus type 1 (HIV-1) and herpes simplex virus type 2 (HSV-2) can coinfect and simultaneously replicate in the same human CD4+ cell: Effect of coinfection on infectious HSV-2 and HIV-1 replication. AIDS Res Hum Retroviruses. 1990; 6:641-647.
8. Sheth PM, Sunderji S, Shin LY, Rebbapragada A, Huibner S, Kimani J, Macdonald KS, Ngugi E, Bwayo JJ, Moses S, Kovacs C, Loutfy M, Kaul R. Coinfection with herpes simplex virus type 2 is associated with reduced HIV-specific T cell responses and systemic immune activation. J Infect Dis. 2008; 197:1394-1401.
9. Sculley TB, Apolloni A, Hurren L, Moss DJ, Cooper DA. Coinfection with A- and B-type Epstein-Barr virus in human immunodeficiency virus-positive subjects. J Infect Dis. 1990; 162:643-648.
10. Engels EA, Biggar RJ, Marshall VA, Walters MA, Gamache CJ, Whitby D, Goedert JJ. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS. 2003; 17:1847-1851.
11. Omland LH, Weis N, Skinhøj P, Laursen A, Christensen PB, Nielsen HI, Møller A, Engsig F, Sørensen HT, Obel N. Impact of hepatitis B virus coinfection on response to highly active antiretroviral treatment and outcome in HIV-infected individuals: A nationwide cohort study. HIV Med. 2008; 9:300-306.
12. Santin M, Mestre M, Shaw E, Barbera MJ, Casanova A, Niubo J, Bolao F, Podzamczer D, Gudiol F. Impact of hepatitis C virus coinfection on immune restoration during successful antiretroviral therapy in chronic human immunodeficiency virus type 1 disease. Eur J Clin Microbiol Infect Dis. 2008; 27:65-73.
13. Weis N, Lindhardt BO, Kronborg G, Hansen AB, Laursen AL, Christensen PB, Nielsen H, Moller A, Sorensen HT, Obel N. Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: A nationwide cohort study. Clin Infect Dis. 2006; 42:1481-1487.
14. Lu Y, Robinson M, Zhang FJ. Human immunodeficiency virus and hepatitis C virus co-infection: Epidemiology, natural history and the situation in China. Chin Med J (Engl). 2009; 122:93-97.
15. Garten RJ, Zhang J, Lai S, Liu W, Chen J, Yu XF. Coinfection with HIV and hepatitis C virus among injection drug users in southern China. Clin Infect Dis. 2005; 41 (Suppl 1):S18-S24.
16. Qian HZ, Vermund SH, Kaslow RA, Coffey CS, Chamot E, Yang Z, Qiao X, Zhang Y, Shi X, Jiang Y, Shao Y, Wang N. Co-infection with HIV and hepatitis C virus in former plasma/blood donors: Challenge for patient care in rural China. AIDS. 2006; 20:1429-1435.
17. Smith JS, Robinson NJ. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: A global review. J Infect Dis. 2002; 186 (Suppl 1):S3-S28.
18. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: A meta-analysis. J Infect Dis. 2002; 185:45-52.
19. Detels R, Wu Z, Rotheram MJ, Li L, Guan J, Yin Y, Liang G, Lee M, Hu L; The National Institute of Mental Health (NIMH) Collaborative HIV Prevention Trial Group. Sexually transmitted disease prevalence and characteristics of market vendors in eastern China. Sex Transm Dis. 2003; 30:803-808.
20. Chen XS, Yin YP, Chen LP, Yu YH, Wei WH, Thuy NT, Smith JS. Herpes simplex virus 2 infection in women attending an antenatal clinic in Fuzhou, China. Sex Transm Infect. 2007; 83:369-370.
21. He N, Cao HJ, Yin YP, Gao MY, Zhang T, Detels R. Herpes simplex virus-2 infection in male rural migrants in Shanghai, China. Int J STD AIDS. 2009; 20:112-114.
22. Chen XS, Yin YP, Liang GJ, Gong XD, Li HS, Poumerol G, Thuy N, Shi MQ, Yu YH. Sexually transmitted infections among female sex workers in Yunnan, China. AIDS Patient Care STDS. 2005; 19:853-860.
23. Wang H, Wang N, Chen RY, Sharp GB, Ma Y, Wang G, Ding G, Wu Z. Prevalence and predictors of herpes simplex virus type 2 infection among female sex workers in Yunnan Province, China. Int J STD AIDS. 2008; 19:635-659.
24. Ngo TD, Laeyendecker O, Li C, Tai H, Cui M, Lai S, Quinn TC. Herpes simplex virus type 2 infection among commercial sex workers in Kunming, Yunnan Province, China. Int J STD AIDS. 2008; 19:694-697.
25. Guiguet M, Boué F, Cadranel J, Lang JM, Rosenthal E, Costagliola D; Clinical Epidemiology Group of the FHDH-ANRS CO4 cohort. Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): A prospective cohort study. Lancet Oncol. 2009; 10:1152-1159.
26. Long JL, Engels EA, Moore RD, Gebo KA. Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals. AIDS. 2008; 22:489-496.
27. Young LS, Rickinson AB. Epstein-Barr virus: 40 years on. Nat Rev Cancer. 2004; 4:757-768.
28. Liu YT. A serological study on anti-CMV and anti-EBV antibodies in population of Beijing, Changzhi Shanxi and Yichang Hubei. Zhonghua Liu Xing Bing Xue Za Zhi. 1989; 10:277-281. (in Chinese)
29. Li YY, Hidaka Y, Kino Y, Mori R. Seroepidemiology of herpes simplex virus type 1 in Yanji, Jilin, China. Microbiol Immunol. 1990; 34:551-555.
30. Dong Z, Li Y, Liu R. IgG and IgM antibodies of Herpes Simplex Virus type-1 and type-2 in 233 maternal and neonatal sera. Int J Gynaecol Obstet. 1998; 63:69-70.
31. Qu JB, Zhang ZW, Shimbo S, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, Higashikawa K, Ikeda M. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci. 2000; 13:243-253.
32. Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009; 20:399-405.
33. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesviruslike DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266:1865-1869.
34. Serraino D, Toma L, Andreoni M, Buttò S, Tchangmena O, Sarmati L, Monini P, Franceschi S, Ensoli B, Rezza G. A seroprevalence study of human herpesvirus type 8 (HHV8) in eastern and Central Africa and in the Mediterranean area. Eur J Epidemiol. 2001; 17:871-876.
35. Whitby D, Howard MR, Tenant-Flowers M, Brink NS, Copas A, Boshoff C, Hatzioannou T, Suggett FE, Aldam DM, Denton AS, et al. Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet. 1995; 346:799-802.
36. Min J, Katzenstein DA. Detection of Kaposi's sarcomaassociated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: Association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels. AIDS Res Hum Retroviruses. 1999; 15:51-55.